BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 11053071)

  • 1. A survey of phenotype II in familial Mediterranean fever.
    Melikoğlu M; Ozdoğan H; Korkmaz C; Kasapçopur O; Arisoy N; Akkuş S; Fresko Z; Yazici H
    Ann Rheum Dis; 2000 Nov; 59(11):910-3. PubMed ID: 11053071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial Mediterranean fever (FMF)-associated amyloidosis in childhood. Clinical features, course and outcome.
    Cakar N; Yalçinkaya F; Ozkaya N; Tekin M; Akar N; Koçak H; Misirlioğlu M; Akar E; Tümer N
    Clin Exp Rheumatol; 2001; 19(5 Suppl 24):S63-7. PubMed ID: 11760404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial Mediterranean fever (FMF) with proteinuria: clinical features, histology, predictors, and prognosis in a cohort of 25 patients.
    Kukuy O; Livneh A; Ben-David A; Kopolovic J; Volkov A; Shinar Y; Holtzman E; Dinour D; Ben-Zvi I
    J Rheumatol; 2013 Dec; 40(12):2083-7. PubMed ID: 24128782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Amyloidosis of familial Mediterranean fever (FMF)--insights to FMF phenotype II].
    Livneh A
    Harefuah; 2006 Oct; 145(10):743-5, 782. PubMed ID: 17111710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloidosis induced, end stage renal disease in patients with familial Mediterranean fever is highly associated with point mutations in the MEFV gene.
    Ben-Chetrit E; Backenroth R
    Ann Rheum Dis; 2001 Feb; 60(2):146-9. PubMed ID: 11156548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial Mediterranean fever in childhood: a single-center experience.
    Barut K; Sahin S; Adrovic A; Sinoplu AB; Yucel G; Pamuk G; Aydın AK; Dasdemir S; Turanlı ET; Buyru N; Kasapcopur O
    Rheumatol Int; 2018 Jan; 38(1):67-74. PubMed ID: 28828621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype-phenotype correlation in patients with familial Mediterranean fever in East Anatolia (Turkey).
    Albayrak F; Selcuk NY; Odabas AR; Cetinkaya R; Pirim I
    Genet Test Mol Biomarkers; 2010 Jun; 14(3):325-8. PubMed ID: 20373849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis.
    Varan Ö; Kucuk H; Babaoglu H; Guven SC; Ozturk MA; Haznedaroglu S; Goker B; Tufan A
    Mod Rheumatol; 2019 Mar; 29(2):363-366. PubMed ID: 29578360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial Mediterranean fever in Germany: clinical presentation and amyloidosis risk.
    Ebrahimi-Fakhari D; Schönland SO; Hegenbart U; Lohse P; Beimler J; Wahlster L; Ho AD; Lorenz HM; Blank N
    Scand J Rheumatol; 2013; 42(1):52-8. PubMed ID: 23137073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of familial Mediterranean fever with amyloidosis as the first manifestation.
    Kutlay S; Yilmaz E; Koytak ES; Tulunay O O; Keven K; Ozcan M; Ertürk S
    Am J Kidney Dis; 2001 Dec; 38(6):E34. PubMed ID: 11728994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotype 2 familial mediterranean fever: evaluation of 22 case series and review of the literature on phenotype 2 FMF.
    Altunoğlu A; Erten Ş; Canoz MB; Yuksel A; Ceylan GG; Balci S; Dogan HT
    Ren Fail; 2013; 35(2):226-30. PubMed ID: 23228227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum galectin-3 levels were associated with proteinuria in patients with Familial Mediterranean Fever.
    Yilmaz H; Inan O; Darcin T; Bilgic MA; Akcay A
    Clin Exp Nephrol; 2015 Jun; 19(3):436-42. PubMed ID: 25059227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of clinical findings of familial Mediterranean fever patients with and without amyloidosis.
    Cefle A; Kamali S; Sayarlioglu M; Inanc M; Ocal L; Aral O; Konice M; Gul A
    Rheumatol Int; 2005 Aug; 25(6):442-6. PubMed ID: 15290087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The M694I/M694I genotype: A genetic risk factor of AA-amyloidosis in a group of Algerian patients with familial Mediterranean fever.
    Ait-Idir D; Djerdjouri B; Bouldjennet F; Taha RZ; El-Shanti H; Sari-Hamidou R; Khellaf G; Benmansour M; Benabadji M; Haddoum F
    Eur J Med Genet; 2017 Mar; 60(3):149-153. PubMed ID: 27956278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arg753Gln TLR-2 polymorphism in familial mediterranean fever: linking the environment to the phenotype in a monogenic inflammatory disease.
    Ozen S; Berdeli A; Türel B; Kutlay S; Yalcinkaya F; Arici M; Besbas N; Bakkaloglu A; Yilmaz E
    J Rheumatol; 2006 Dec; 33(12):2498-500. PubMed ID: 17013994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEFV and SAA1 genotype associations with clinical features of familial Mediterranean fever and amyloidosis in Armenia.
    Atoyan S; Hayrapetyan H; Sarkisian T; Ben-Chetrit E
    Clin Exp Rheumatol; 2016; 34(6 Suppl 102):72-76. PubMed ID: 27791951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between basal proteinuria levels and pregnancy outcomes in familial Mediterranean fever.
    Iskender D; Kara O; Ozturk Kaymak A; Daglar HK; Kirbas A; Iskender CT; Kaymak O; Celen S
    J Obstet Gynaecol; 2020 Nov; 40(8):1102-1105. PubMed ID: 32270724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin Converting Enzyme Gene Insertion/Deletion Variant and Familial Mediterranean Fever-related Amyloidosis.
    Nursal AF; Turkmen E; Uzun Kaya S; Tekcan A; Sezer O; Celik SD; Yigit S
    Iran J Kidney Dis; 2018 May; 12(3):150-155. PubMed ID: 29891744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotype-genotype correlation in familial Mediterranean fever: evidence for an association between Met694Val and amyloidosis.
    Shohat M; Magal N; Shohat T; Chen X; Dagan T; Mimouni A; Danon Y; Lotan R; Ogur G; Sirin A; Schlezinger M; Halpern GJ; Schwabe A; Kastner D; Rotter JI; Fischel-Ghodsian N
    Eur J Hum Genet; 1999 Apr; 7(3):287-92. PubMed ID: 10234504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial Mediterranean fever in children: report of a large series and discussion of the risk and prognostic factors of amyloidosis.
    Saatçi U; Ozen S; Ozdemir S; Bakkaloglu A; Besbas N; Topaloglu R; Arslan S
    Eur J Pediatr; 1997 Aug; 156(8):619-23. PubMed ID: 9266193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.